DVLA warning as drivers could lose licence over three common medications
The DVLA has issued a warning to drivers, road users and motorists that they could have their driving…
Over Half a Million Blood Pressure Pills Recalled: Is Yours on the List?
If you or someone in your household takes blood pressure medication, now is the time to check your…
Paxton makes “extraordinary request” to block Tylenol maker from paying shareholders
by Eleanor Klibanoff, The Texas Tribune November 6, 2025 Texas Attorney General Ken Paxton is asking a judge…
Pharmacy settles lawsuit over counterfeit Ozempic sales
IOWA’S NEWS LEADER. KAYLA. THANKS. NEW AT SIX, A PHARMACY IN EASTERN IOWA ACCUSED OF SELLING COUNTERFEIT OZEMPIC…
RFK Jr. stands by his position on Tylenol for pregnant women
RFK Jr. says ‘not sufficient’ proof linking Tylenol and autism Health Secretary Robert F. Kennedy Jr. told reporters…
Nationwide ADHD Medication Recall Update as FDA Sets Risk Level
A voluntary, nationwide recall of Lisdexamfetamine dimesylate capsules, a drug often used to treat Attention Deficit Hyperactivity Disorder…
FDA Approves Caplyta for Adjunctive Treatment of Major Depressive Disorder
The US Food and Drug Administration (FDA) has approved Johnson & Johnson’s lumateprone (Caplyta) as an adjunctive therapy for…
Texas AG Ken Paxton moves to block Tylenol maker dividend amid lawsuit over marketing
Texas Attorney General Ken Paxton has filed a motion to block Kenvue, the maker of Tylenol, from issuing…
Drug company representative collapses during Oval Office event
A representative from a drug manufacturer fainted during an event at the White House on Thursday, where President…
Weight loss gets cheaper: New White House deal slashes prices of Ozempic and Wegovy |
The cost of some of the most widely used weight loss medications in the United States is set…
Suburban chiropractor accused of secretly recording more than 100 patients
ST. CHARLES, Ill. (WGN) — A west suburban chiropractor is accused of secretly video taping his patients as…
Mark Cuban tries to shake up biosimilar pricing with a version of J&J’s Stelara
In its latest bid to shake up the prescription drug market, the Mark Cuban Cost Plus Drug Company…